Masakatsu Motomura Selected Research

Myasthenia Gravis

5/2024	[Muscle-Specific Receptor Tyrosine Kinase Antibody Positive Myasthenia Gravis].
12/2019	Preoperative risks of post-operative myasthenic crisis (POMC): A meta-analysis.
9/2019	MGTX extension study longitudinally favors early thymectomy in non-thymomatous young-adult patients with AChR antibody-positive myasthenia gravis.
5/2018	Anti-MuSK Antibody-positive Myasthenia Gravis Successfully Treated with Outpatient Periodic Weekly Blood Purification Therapy.
1/2018	Rationale for the clinical guidelines for myasthenia gravis in Japan.
1/2018	Heterogeneity of auto-antibodies against nAChR in myasthenic serum and their pathogenic roles in experimental autoimmune myasthenia gravis.
1/2017	Analysis of peripheral B cells and autoantibodies against the anti-nicotinic acetylcholine receptor derived from patients with myasthenia gravis using single-cell manipulation tools.
9/2015	[The role of autoantibodies in myasthenia gravis].
1/2015	Anti-MuSK Antibody-positive Myasthenia Gravis Mimicking Amyotrophic Lateral Sclerosis.
3/2014	[Autoantibodies detected in acetylcholine receptor antibody-negative myasthenia gravis].

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masakatsu Motomura Research Topics

Disease

35	Myasthenia Gravis 05/2024 - 01/2003
9	Neoplasms (Cancer) 01/2024 - 09/2003
8	Lambert-Eaton Myasthenic Syndrome (Lambert-Eaton Syndrome) 01/2024 - 01/2003
7	Thymoma (Thymic Carcinoma) 01/2014 - 05/2007
5	Muscle Weakness 05/2018 - 09/2006
5	Myositis (Idiopathic Inflammatory Myopathies) 01/2015 - 09/2005
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2024 - 06/2018
4	Disease Progression 01/2022 - 01/2007
3	Paraneoplastic Cerebellar Degeneration 01/2022 - 01/2003
3	Neurologic Manifestations (Neurological Manifestations) 02/2019 - 07/2011
3	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 02/2011
2	Deglutition Disorders (Dysphagia) 05/2024 - 05/2018
2	Cerebellar Ataxia (Dysmetria) 02/2019 - 05/2008
2	Cerebellar Diseases (Cerebellar Syndrome) 01/2019 - 07/2011
2	Vision Disorders (Hemeralopia) 06/2018 - 04/2015
2	Thymus Hyperplasia 01/2018 - 01/2014
2	Optic Neuritis (Retrobulbar Neuritis) 01/2016 - 04/2015
2	Lymphadenopathy 01/2016 - 12/2011
2	Infections 04/2015 - 01/2012
2	Polymyositis 01/2015 - 09/2005
2	Muscular Diseases (Myopathy) 01/2015 - 11/2003
2	Leukocytosis (Pleocytosis) 01/2013 - 01/2013
2	Encephalitis (Encephalitis, Rasmussen) 01/2012 - 11/2010
2	Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital) 07/2011 - 06/2008
2	Dermatomyositis (Dermatopolymyositis) 01/2011 - 09/2005
2	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 01/2007 - 01/2007
1	Inflammation (Inflammations) 01/2022
1	Neuromyelitis Optica (Devic's Disease) 01/2019
1	Neuroendocrine Carcinoma 02/2018
1	Experimental Autoimmune Myasthenia Gravis (Autoimmune Experimental Myasthenia Gravis) 01/2018
1	Immunoglobulin G4-Related Disease 01/2016
1	Multiple Sclerosis 01/2016
1	Pain (Aches) 04/2015
1	Central Nervous System Lupus Vasculitis 04/2015
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2015
1	Neuromuscular Diseases (Neuromuscular Disease) 09/2014
1	Edema (Dropsy) 01/2014
1	Arthritis (Polyarthritis) 01/2014
1	Rheumatoid Arthritis 01/2014
1	Macrophage Activation Syndrome 04/2013
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 04/2013
1	Hypothyroidism 01/2013
1	Pulmonary Sarcoidosis 01/2013
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2013
1	Graves Disease (Basedow Disease) 01/2013

Drug/Important Bio-Agent (IBA)

21	AntibodiesIBA 01/2024 - 02/2005
19	AutoantibodiesIBA 01/2022 - 10/2009
16	muskIBA 05/2024 - 02/2005
15	Cholinergic ReceptorsIBA 05/2024 - 01/2003
10	Proteins (Proteins, Gene)FDA Link 01/2019 - 09/2005
8	Calcium Channels (Calcium Channel)IBA 01/2024 - 01/2003
8	myasthenia gravis anti-skeletal muscle antibody (ASMA)IBA 05/2018 - 06/2005
7	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2024 - 08/2011
6	SteroidsIBA 04/2015 - 03/2002
5	Immunoglobulin G (IgG)IBA 01/2022 - 07/2009
5	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2018 - 02/2005
5	Tacrolimus (Prograf)FDA LinkGeneric 01/2015 - 05/2007
4	Phosphotransferases (Kinase)IBA 05/2024 - 07/2009
4	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2018 - 09/2012
4	Prednisolone (Predate)FDA LinkGeneric 01/2018 - 12/2011
3	AntigensIBA 01/2022 - 09/2005
3	Q-Type Calcium Channels (Q-Type Calcium Channel)IBA 02/2019 - 01/2003
3	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 05/2013 - 11/2009
3	LDL Receptors (LDL Receptor)IBA 05/2013 - 02/2011
3	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 06/2012 - 11/2009
2	Myelin-Oligodendrocyte GlycoproteinIBA 01/2016 - 04/2015
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2015 - 08/2002
2	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 11/2011 - 02/2011
2	AcetylcholinesteraseIBA 07/2011 - 09/2006
2	Complement System Proteins (Complement)IBA 04/2010 - 01/2003
2	tau Proteins (tau Protein)IBA 01/2007 - 01/2007
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 04/2022
1	margatoxinIBA 09/2019
1	Interleukin-8 (Interleukin 8)IBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Claudin-5IBA 01/2019
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2019
1	Semaphorin-3AIBA 06/2018
1	Monoclonal AntibodiesIBA 01/2018
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2016
1	Fluorescein (Funduscein)FDA LinkGeneric 04/2015
1	CytokinesIBA 04/2015
1	Amino Acids FDA Link 01/2015
1	GlucocorticoidsIBA 01/2015
1	Branched-Chain Amino AcidsIBA 01/2015
1	Muscle Proteins (Muscle Protein)IBA 09/2014
1	Anti-Citrullinated Protein AntibodiesIBA 01/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014
1	Indicators and Reagents (Reagents)IBA 09/2012
1	MacrolidesIBA 09/2012
1	Immunologic Factors (Immunomodulators)IBA 09/2012
1	anti-ryanodine receptor autoantibodyIBA 06/2012
1	Dacarbazine (DIC)FDA LinkGeneric 01/2012

Therapy/Procedure

11	Therapeutics 01/2022 - 03/2002
4	Thymectomy 12/2019 - 06/2008
3	Activities of Daily Living (ADL) 04/2022 - 01/2015
2	Drug Therapy (Chemotherapy) 04/2022 - 09/2003
2	Bite Force (Occlusal Forces) 09/2012 - 07/2010
2	Plasma Exchange 07/2005 - 08/2002
1	Thyroidectomy 01/2013